Opioid Use Disorders
12 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Brain Dopaminergic Signaling in Opioid Use Disorders (NCT03190954) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2017-08-17 |
| Primary Care Intervention to Reduce Prescription Opioid Overdoses (NCT02464410) | VA Office of Research and Development | 2016-08-04 |
| The Mobile Monitoring of Vital Signs in Opioid Users (NCT02647073) | University of British Columbia | 2016-08-01 |
| Mindfulness-Oriented Recovery Enhancement For Chronic Pain and Prescription Opioid Misuse in Primary Care (NCT02602535) | University of Utah | 2016-01-01 |
| Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence (NCT02651584) | Braeburn Pharmaceuticals | 2015-12-01 |
| Prevalence and Predictors of Prolonged Post-surgical Opioid Use: a Prospective Observational Cohort Study (NCT02571400) | University of Notre Dame Australia | 2015-10-01 |
| Injectable Pharmacotherapy for Opioid Use Disorders (IPOD) (NCT02110264) | University of California, Los Angeles | 2015-06-01 |
Track Opioid Use Disorders automatically
Every clearance here is in the API, with alerts when new ones post.